China Securities Co., Ltd. (06066) has elected Dong Hongfu as a non-executive director.
CITIC Securities (06066) announced that Mr. Dong Hongfu was elected as a non-executive director of the third board of directors at the temporary shareholders meeting. Mr. Dong Hongfu was appointed as a member of the board of directors' Risk Management Committee and Audit Committee. Mr. Yan Xiaolei submitted his resignation to the board of directors due to work reasons, resigning from his positions as non-executive director, member of the Risk Management Committee, and member of the Audit Committee of the board of directors, effective from the day a new non-executive director is elected at this temporary shareholders meeting.
China Securities Co., Ltd. announced that Mr. Dong Hongfu was elected as a non-executive director of the third board of directors at the extraordinary general meeting. He was also appointed as a member of the Risk Management Committee and Audit Committee of the board of directors. Mr. Yan Xiaolei submitted his resignation from the company's board of directors, citing work reasons. He resigned from his positions as non-executive director, member of the Risk Management Committee, and member of the Audit Committee, effective from the day the new non-executive director was elected at the extraordinary general meeting.
Related Articles

CHANGHONG JH (03991) announced its annual performance with a net profit of approximately HK$401 million, representing a year-on-year increase of 5.69%.

ISP Global (08487): Yuan Shuangshun resigns as executive director and authorized representative.

VISION SYNERGY (00627) announced annual performance, with a net loss attributable to shareholders of 168 million yuan, a year-on-year decrease of 80.29%.
CHANGHONG JH (03991) announced its annual performance with a net profit of approximately HK$401 million, representing a year-on-year increase of 5.69%.

ISP Global (08487): Yuan Shuangshun resigns as executive director and authorized representative.

VISION SYNERGY (00627) announced annual performance, with a net loss attributable to shareholders of 168 million yuan, a year-on-year decrease of 80.29%.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


